Brain-Permeable Nanoparticle Coating for Sustained CNS Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The blood-brain barrier and other anatomical and physiological barriers pose significant challenges for the widespread distribution and sustained release of therapeutic, prophylactic, and diagnostic agents in the brain, limiting their efficacy in treating brain diseases.
Innovation Solution
Nanoparticles made of Generally Recognized As Safe (GRAS) materials, such as PLGA, coated with triblock copolymers like PEO-PPO-PEO, enhance diffusion and penetration into the brain parenchyma, allowing for sustained release of therapeutic agents via intracranial administration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If nanoparticles are delivered to the brain, then drug payload and therapeutic distribution are improved, but penetration through blood-brain barrier and brain tissue barriers is limited
Solution Approach 1:
The patent changes physical and chemical parameters of nanoparticles by coating them with triblock copolymers (PEO-PPO-PEO) to alter surface properties, enabling enhanced penetration through blood-brain barrier and brain tissue barriers while maintaining high drug payload capacity
Solution Approach 2:
The invention uses composite nanoparticle structures combining GRAS materials (such as PLGA core) with triblock copolymer coatings to create a system that simultaneously achieves high drug loading and effective barrier penetration
2Reliability
If nanoparticles are used for drug delivery, then therapeutic efficacy is improved, but distribution within brain parenchyma is poor
Solution Approach 1:
The patent modifies nanoparticle surface parameters by incorporating triblock copolymer coatings that change interaction properties with brain extracellular matrix, enabling widespread distribution throughout the brain parenchyma while maintaining therapeutic efficacy
Solution Approach 2:
The triblock copolymer coating acts as an intermediary between the nanoparticle core and the brain tissue environment, facilitating enhanced distribution throughout the brain parenchyma by mediating interactions with the extracellular matrix
3Quantity of substance
If nanoparticles are administered, then drug delivery is achieved, but release duration is limited
Solution Approach 1:
The patent designs nanoparticle systems with sustained release characteristics, where the nanoparticle core gradually releases therapeutic agents over extended periods, ensuring continuous therapeutic action rather than transient effects
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanoparticles achieve widespread and sustainable drug delivery in the brain, offering higher drug payload and prolonged release durations, enhancing therapeutic distribution and safety for treating neurological disorders.
Implementation Method 1
The nanoparticles exhibit increased rates of diffusion through the brain parenchyma
Implementation Method 2
The coating material can be a surfactant or a hydrophilic material, such as a hydrophilic polymer
Data Source
AI summary
Non-adhesive brain-permeable nanoparticles as large as 200 nm can diffuse rapidly in the brain ECS preferably made entirely of generally recognized as safe (GRAS) materials having neutral surface charge are described. Synergistic improvement of therapeutic distribution enabled by these non-adhesive, brain-permeable nanoparticles and osmosis-driven brain extracellular matrix (ECM) modulation will significantly enhance drug and gene delivery within the CNS, offering higher drug payload, improved drug loading efficiency, and significantly longer drug release durations.